Reduction of Suicidality in Patients with Schizophrenia Receiving Clozapine

Author： Reinstein M.J. Chasonov M.A. Colombo K.D. Jones L.E. Sonnenberg J.G.

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.5, 2002-05, pp. : 341-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Despite safety concerns, clozapine has a unique profile of clinical benefits in patients with treatment-resistant schizophrenia or schizophrenia-associated suicidality

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. : 9-13

Adis International

Access to resources Recommend Favorite

Clozapine: In Prevention of Suicide in Patients with Schizophrenia or Schizoaffective Disorder

By Wagstaff A.J. Perry C.M.

CNS Drugs, Vol. 17, Iss. 4, 2003-01 ,pp. : 273-280

Adis International

Access to resources Recommend Favorite

Antibacterials are prescribed more frequently among patients receiving clozapine

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 433, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

A Bioequivalence Study of Brand and Generic Clozapine in Patients with Schizophrenia: Pharmacokinetic and Tolerability Findings

By Sramek J.J.

Clinical Drug Investigation, Vol. 17, Iss. 1, 1999-01 ,pp. : 51-58

Adis International

Access to resources Recommend Favorite

Suicidality and second generation anytipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period

By Barak Y Mirecki I Knobler HY Natan Z Aizenberg D

Psychopharmacology, Vol. 175, Iss. 2, 2004-09 ,pp. : 215-219

Springer Publishing Company

Access to resources Recommend Favorite